Clicky

Creo Medical Group Plc(CREO)

Description: Creo Medical Group plc is a United Kingdom-based medical device company. The Company focuses on the field of surgical endoscopy. The Company focuses on the development and commercialization of minimally invasive surgical devices, initially in the area of gastrointestinal (GI) surgery and lung cancer. The Company has developed CROMA, which is an electrosurgical platform that can deliver microwave and bipolar radiofrequency through a single accessory port. The Company's surgical system CROMA combines bipolar radiofrequency for localized cutting and microwave energy for controlled coagulation, which provides physicians with simplified and controlled surgical solutions. The Company's pipeline portfolio of instruments is targeted at three therapeutic endoscopic specialties: lower GI; lung/bronchoscopy and upper GI.


Keywords: Medicine Cancer Gas Surgery Pipe Microwave Medical Device Radio Lung Cancer Endoscopy IPO Coagulation Diagnostic Gastroenterology Surgical Solutions Microwave Energy

Home Page: creomedical.com

CREO Technical Analysis

Creo House
Chepstow, NP16 5UH
United Kingdom
Phone: 44 1291 606005


Officers

Name Title
Mr. Craig Jonathan Gulliford CEO & Exec. Director
Prof. Christopher Paul Hancock Founder, CTO & Exec. Director
Mr. Richard John Rees ACA CFO, Company Sec. & Exec. Director
Mr. David Gerard Woods Chief Commercial Officer & Exec. Director
Mr. Phil Hales Sales & Marketing Director

Exchange: LSE

Country: UK

Currency: Pence sterling (p)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 1.0696
Price-to-Sales TTM: 2.4845
IPO Date:
Fiscal Year End: June
Full Time Employees: 316
Back to stocks